Back Login for AI Analysis

    INO (STOCKS)

    Inovio Pharmaceuticals, Inc.

    $1.080000
    +0.020000 (+1.89%)
    Prev close: $1.060000
    Company Information
    Exchange
    XNAS
    Sector
    Health Technology
    Industry
    Pharmaceuticals: Major
    CEO
    Jacqueline E. Shea
    Asset Type
    stocks
    Website
    Visit
    Fundamentals
    Market Cap
    $89.75M
    Employees
    134
    P/E (TTM)
    -0.56
    P/B (TTM)
    3.04
    Dividend Yield
    —
    Technical Indicators
    SMA 10
    —
    SMA 20
    —
    SMA 50
    —
    EMA 9
    —
    EMA 21
    —
    RSI
    —
    MACD State
    —
    Analyst Recommendations
    3
    Strong Buy
    4
    Buy
    3
    Hold
    0
    Sell
    Recent News

    No recent news found for this ticker.

    Earnings Surprises
    Period Actual Estimate Surprise Surprise %
    Dec 2025 (Q4)
    		 $0.06 $-0.36 +0.4214 +116.60%
    Sep 2025 (Q3)
    		 $-0.87 $-0.43 -0.4426 -103.56%
    Jun 2025 (Q2)
    		 $-0.61 $-0.62 +0.0053 +0.86%
    Mar 2025 (Q1)
    		 $-0.41 $-0.75 +0.3354 +45.00%
    Financial Statements
    TTM (Dec 2025)
    Revenues $65.34K
    Benefits Costs and Expenses $85.01M
    Costs And Expenses $85.01M
    Operating Expenses $86.89M
    Research and Development $54.21M
    Other Operating Expenses $32.68M
    Operating Income/Loss -$86.82M
    Income/Loss From Continuing Operations After Tax -$84.95M
    Income/Loss From Continuing Operations Before Tax -$84.95M
    Income Tax Expense/Benefit $0.00
    Net Income/Loss -$84.95M
    Net Income/Loss Attributable To Noncontrolling Interest $0.00
    Net Income/Loss Attributable To Parent -$84.95M
    Net Income/Loss Available To Common Stockholders, Basic -$84.95M
    Participating Securities, Distributed And Undistributed Earnings/Loss, Basic $0.00
    Preferred Stock Dividends And Other Adjustments $0.00
    Basic Earnings Per Share -$1.81
    Diluted Earnings Per Share -$1.81
    Basic Average Shares 46,886,413
    Diluted Average Shares 46,886,413
    Assets $74.31M
    Current Assets $61.12M
    Cash $58.50M
    Other Current Assets $2.62M
    Noncurrent Assets $13.19M
    Fixed Assets $2.53M
    Other Non-current Assets $10.66M
    Liabilities $50.21M
    Current Liabilities $43.67M
    Noncurrent Liabilities $6.55M
    Equity $24.10M
    Equity Attributable To Noncontrolling Interest $0.00
    Equity Attributable To Parent $24.10M
    Liabilities And Equity $74.31M
    Net Cash Flow From Operating Activities -$88.63M
    Net Cash Flow From Operating Activities, Continuing -$88.63M
    Net Cash Flow From Investing Activities $14.04M
    Net Cash Flow From Investing Activities, Continuing $14.04M
    Net Cash Flow From Financing Activities $53.05M
    Net Cash Flow From Financing Activities, Continuing $53.05M
    Exchange Gains/Losses $0.00
    Net Cash Flow -$21.54M
    Net Cash Flow, Continuing -$21.54M
    Comprehensive Income/Loss -$84.91M
    Comprehensive Income/Loss Attributable To Noncontrolling Interest $0.00
    Comprehensive Income/Loss Attributable To Parent -$84.91M
    Other Comprehensive Income/Loss -$84.91M
    Related Companies
    MRNA